Dr. Craig Crews of the Crews Laboratory at Yale University describes his discovery and development of carfilzomib (Kyprolis) and what it takes to get a new drug across the

Dr. Craig Crews of the Crews Laboratory at Yale University describes his discovery and development of carfilzomib (Kyprolis) and what it takes to get a new drug across the
Event Description
Dr. Craig Crews, PhD, Crews Laboratory at Yale University
Interview date: September 13, 2013
On this week's show, Dr. Craig Crews of the Crews Laboratory describes his discovery and development of carfilzomib. He discusses the challenge labs have with only 10 out of 100 submitted research projects getting NIH funding and the need for patients to push for greater federal funding if we are to have more successes in the future. He describes a drug's "Valley of Death" - or the jump from the academic institution into the next stage of development, and how he overcame that for carfilzomib by creating his own biotech company. He describes the drug funding continuum and the important role of new biotechs to fill an existing gap and get a drug across the finish line. He shares the fast-track success of carfilzomib because the Phase II results were so promising and his lab's quest to teach the ability to pick future winners by looking at promising outliers.
Schedule & Agenda
Speakers & Moderators

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org






Get the Latest Multiple Myeloma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.